Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Experimental Hematology & Oncology|May 3, 2022
A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationMeng-Zhu Shen, Shen-Da Hong, Rui Lou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 12, 2018
Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor EraYu-Juan Xue, Yi-Fei Cheng, Ai-Dong Lu, et al.
Journal of Hematology & Oncology|September 4, 2019
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter studyLan-Ping Xu, Shun-Qing Wang, Yan-Ru Ma, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
Incidence, Risk Factors, Outcomes, and Risk Score Model of Acute Pancreatitis after Allogeneic Hematopoietic Stem Cell TransplantationXing-Lin Wang, Wei Han, Peng Zhao, et al.
Clinical Transplantation|November 22, 2020
The incidence, clinical outcome, and protective factors of mixed chimerism following hematopoietic stem cell transplantation for severe aplastic anemiaZheng-Li Xu, Yi-Fei Cheng, Yuan-Yuan Zhang, et al.
Frontiers in Oncology|January 24, 2022
Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationShuang Fan, Meng-Zhu Shen, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|August 22, 2018
The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allograftsJing Liu, Rui Ma, Yan-Rong Liu, et al.
British Journal of Haematology|September 28, 2024
Mega-dose decitabine conditioning and prophylactic donor lymphocyte infusion for patients with relapsed/refractory AML with active disease at the time of allogeneic haematopoietic cell transplantation: A multicenter prospective phase II studyMeng Lv, Chen-Hua Yan, Rui Ma, et al.
Pageof 16